Prevention of cancer and the dose-effect relationship: The carcinogenic effects of ionizing radiations;La prévention du cancer et la relation dose-effet : l'effet cancérogène des rayonnements ionisants

Cancer/Radiotherapie

Volumn 13, Issue 4, 2009, Pages 238-258

  Tubiana, M ^a  

^a Laboratoire d'Excellence Inflamex   (France)

Author keywords

Cancer prevention; Carcinogenesis; Initiation; Progression; Promotion; Radiocarcinogenesis

Indexed keywords

ANGIOGENIC FACTOR; CATALASE; DNA; MUTAGENIC AGENT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

CANCER PREVENTION; CANCER RADIOTHERAPY; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CELL CYCLE; CELL DEATH; CELL IMMORTALIZATION; CELL PROLIFERATION; DNA DAMAGE; DNA REPAIR; DOSE RESPONSE; GENE AMPLIFICATION; GENETIC STABILITY; GENOME; GROWTH RATE; HUMAN; HYPOXIA; IONIZING RADIATION; METASTASIS; MICROENVIRONMENT; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; SHORT SURVEY;

ANIMALS; APOPTOSIS; CARCINOGENS; CELL COMMUNICATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENVIRONMENTAL POLLUTANTS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PRECANCEROUS CONDITIONS; RADIATION INJURIES; RADIOGRAPHY; REACTIVE OXYGEN SPECIES;

EID: 67649387945     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2009.03.003     Document Type: Short Survey

References (163)

1. Abdel-Wahab M., Reis I.M., and Hamilton K. Second primary cancer after radiotherapy for prostate cancer - A SEER analysis of brachytherapy versus external beam radiotherapy. Int J Radiat Oncol Biol Phys 72 (2008) 58-68
2. o 2. (Tubiana M., Aurengo A., Averbeck D., Bonnin A., Le Guen B., Masse R., et al. editors.) Relation dose-effet et estimation de risqué cancérogène des faibles doses. Annexe 1 : Les mécanismes de l'oncogenèse, Monier R ; Annexe 2 : Phénomènes physiques et biologiques de l'irradiation, Averbeck D ; Annexe 3 : Les données de l'expérimentation animale, Masse R ; Annexe 4 : Données épidémiologiques sur les effets cancérigènes des faibles doses de rayonnements ionisants, de Vathaire F. (www.academiemedecine.fr/actualites/rapports.asp) (Paris Nucleon 2005) ISBN 2-84332-018-6.
3. Affset-Inserm. Cancer et environnement : Expertise Collective. Les Éditions Inserm, 2008 Paris, 914 pages.
4. Ames B.N., and Gold L.S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 249 (1990) 970-971
5. Ames B.N., and Gold L.S. Environmental pollution, pesticides and the prevention of cancer: misconceptions. FASEB J 11 (1997) 1041-1052
6. Amundson S.A., Lee R.A., Koch-Paiz C.A., Meltzer P., Trent J.M., and Fornace Jr. A.J. Differential responses of stress genes to low dose-rate gamma irradiation. Mol Cancer Res 1 (2003) 445-452
7. Anand P., Kunnumakara A.B., Sundaram C., Harikumar K.B., Tharakan S.T., Lai O.S., et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 25 (2008) 2097-2116
8. Averbeck D. Effet des rayonnements sur l'AND et les chromosomes. Chap III pp. 79-184. Radiobiologie (M. Tubiana, coordinateur). Hermann Médecine. Paris 2008.
9. Barcellos-Hoff M.H. Integrative Radiation Carcinogenesis: interactions between cell and tissue responses to DNA damage. Sem Cancer Biol 15 (2005) 138-148
10. Barnes D.E., and Lindahl T. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu. Rev. Genet. 38 (2004) 445-476
11. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., et al. Oncogene induced senescence is part of the tumorigenesis barrier imposed by the DNA damage checkpoints. Nature 444 (2006) 633-637
12. Bauer G. Low dose radiation and intercellular induction of apoptosis: potential implication for the control of oncogenesis. Int J Radiat Biol 83 (2007) 1-16
13. Baylin S.B., and Ohm J.E. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction. Nature Reviews/Cancer 6 (2006) 107-116
14. BEIR VII Phase 2: Health Risks from Exposure to Low Levels of Ionizing Radiation.;1; Board on Radiation Effects Research 2006 http://netonnapedu/books/030909156X/html/. National Academies press.
15. Belkacemi Y., Chauvet M.P., Giard S., Poupon L., Castellanos M.E., Villette S., et al. Partial breast irradiation: high dose rate peroperative brachytherapy technique using the MommoSite. Cancer Radiother 7 (2003) 129-136
16. Belyakov O.V., Folkard M., and Mothersill C. Bystander induced differentiation. A major response to targeted irradiation of a urothelial explant model. Mutat Res 597 (2006) 43-49
17. Berrington A., and Darby S. Risk of cancer from diagnostic X-rays, estimates for the UK and 14 other countries. Lancet 363 (2004) 345-351
18. Bhatia S., Robison L.L., Oberlin O., Greenberg M., Bunin G., Fossati-Bellani F., et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334 (1996) 745-751
19. Boffetta P., van der Hel O., Norppa H., Fabianova E., Fucic A., Gundy S., et al. Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe. Am J Epidemiol 165 (2007) 36-43
20. Boffetta P., McLaughlin J.K., La Vecchia C., Tarone R.E., Lipworth L., and Blot W.J. False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst 100 (2008) 988-995
21. Boffetta P., Tubiana M., Hill C., Boniol M., Aurengo A., Masse R., et al. The causes of cancer in France. Ann Oncol 20 (2009) 550-555
22. Boice J.D., Engholm G., Kleinerman R.A., Blettner M., Stovall M., Lisco H., et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 116 (1988) 3-55
23. Boice J.D., Preston D., Davis F.G., and Monson R.R. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 125 (1991) 214-222
24. Boice J.D.J., Morin M.M., and Glass A.G. Diagnostic X-ray procedures and risk of leukemia, lymphoma and multiple myeloma. JAMA 265 (1991) 1290-1294
25. Bonassi S., Ugolini D., Kirsch-Volders M., Stromberg U., Vermeulen R., and Tucker J.D. Human population studies with cytogenetic biomarkers: Review of the literature and future prospectives. Env Mol Mutagen 45 (2005) 258-270
26. Boucher D., Hindo J., and Averbeck D. Increased repair of gamma-induced DNA double-strand breaks at lower dose-rate in CHO cells. Can J Physiol Pharmacol 82 (2004) 125-132
27. Boulton E., Cleary H., Papworth D., and Plumb M. Susceptibility to radiation-induced leukaemia-lymphoma is genetically separable from sensitivity to radiation-induced genomic instability. Int J Radiat Biol 77 (2001) 21-29
28. Boutou O., Guizard A.V., Slama R., Pottier D., and Spira A. Population mixing and leukaemia in young people around the La Hague nuclear waste processing plant. Br J Cancer 87 (2002) 740-745
29. Brash D.E. Sunlight and the onset of skin cancer. Trends Genet 13 (1997) 410-414
30. Breckow J. Linear-no-threshold is a radiation-protection standard rather than a mechanistic effect model. Radiat Environ Biophys 44 (2006) 257-260
31. Brenner D.J., Doll R., Goodhead D.T., Hall E.J., Land C.E., Little J.B., et al. Cancer risk attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci USA 100 (2003) 13761-13766
32. Brenner D.J., and Sachs R.K. Estimating radiation-induced cancer risks at very low doses: rationale for using a linear no-threshold approach. Radiat Environ Biophys 44 (2006) 253-256
33. Brenner D.J., and Hall E.J. Computed tomography - an increasing source of radiation exposure. N Engl J Med 357 (2007) 2277-2284
34. Campisi J. Senescent cells, tumor suppression and organism aging. Cell 120 (2005) 513-522
35. Carbone M.C., Pinto M., Antonelli F., Amicarelli F., Balata M., Belli M., et al. The Cosmic Silence experiment: on the putative role of environmental ionizing radiation. Radiat Environ Biophys 48 (2009) 189-196
36. Cardis E., Kesminiene A., Ivanov V., Malakhova I., Shibata Y., Khrouch V., et al. Risk of thyroid cancer after exposure to I131 in childhood. J Nat Cancer Inst 97 (2005) 724-732
37. Cardis E., Howe G., Ron E., Bebeshko V., Bogdanova T., Bouville A., et al. Cancer consequences of the Chernobyl accident: 20 years after. J Radiol Prot 26 (2006) 127-140
38. Cardis E., Vrijheid M., Blettner M., Gilbert E., Hakama M., Hill C., et al. The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry. Radiat Res 167 (2007) 396-416
39. Carnes B.A., Groer P.G., and Kotec T.J. Radium dial workers: Issues concerning dose response and modeling. Radiat Res 147 (1997) 707-714
40. Chalmers A., Johnston P., Woodcock M., Joiner M., and Marples B. PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation. Int J Radiation Oncology Biol Phys 58 (2004) 410-419
41. Charles M.W. LNT - an apparent rather than a real controversy?. J Radiol Prot 26 (2006) 325-329
42. Chaturvedi A.K., Engels E.A., Gilbert E.S., Chen B.E., Storm H., Lynch C.F., et al. Second cancers among 104, 760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 99 (2007) 1634-1643
43. Cohen S.M., and Ellwein L.B. Cell proliferation in carcinogenesis. Science 249 (1990) 503-504
44. Cohen B.L. The Linear No-Threshold Theory of radiation carcinogenesis should be rejected. Am Phys Surg 3 (2008) 70-76
45. Collis S.J., Schwaninger J.M., Ntambi A.J., Keller T.W., Nelson W.G., Dillehay L.E., et al. Evasion of early cellular response mechanisms following low level radiation induced DNA damage. J Biol Chem 279 (2004) 49624-49632
46. Day T.K., Zeng G., Hooker A.M., Bhat M., Scott B.R., Turner D.R., et al. Adaptive response for chromosomal inversions on pKZ1 mouse prostate induced by low doses of X radiation delivered after a high dose. Radiat Res 167 (2007) 682-692
47. de Vathaire F. Annexe 4 : Les données épidémiologiques. In: Rapport conjoint n° 2 Académie Nationale de Médecine, Institut de France - Académie des Sciences (30 mars 2005) (M. Tubiana, A. Aurengo, D. Averbeck, et al.) La relation dose-effet et l'estimation des effets cancérogènes des faibles doses de rayonnements ionisants (Édition Nucleon) pp 147-168.
48. de Vathaire F., Hawkins M., Campbell S., Oberlin O., Raquin M.A., Schlienger J.Y., et al. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer 79 (1999) 1884-1893
49. Diallo I., Lamon A., Shamsaldin A., Grimaud E., de Vathaire F., and Chavaudra J. Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol 38 (1996) 269-271
50. Dikomey E., and Brammer I. Relationship between cellular radiosensitivity and non-repaired double-strand breaks studied for different growth states, dose rates and plating conditions in a normal fibroblast line. Int J Radiat Biol 76 (2000) 773-781
51. Doll R., and Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol 70 (1997) 130-139
52. Doll R., Berrington A., and Darby S.C. Low mortality of British radiologists. Br J Radiol 78 (2005) 1057-1058
53. Doody M.M., Lonstein J.E., Stovall M., Hacker D.G., Luckyanov N., and Land C.E. U.S. Scoliosis Cohort Study Collaborators. Breast cancer mortality following diagnostic X-rays: Findings from the U. S. Scoliosis Cohort Study. Spine 25 (2000) 2052-2063
54. Dörr W., and Herrmann T. Cancer induction by radiotherapy: Dose dependence and spatial relationship to irradiated volume. J Radiol Prot 22 (2002) A117-A121
55. Duport P. A database of cancer induction by low dose radiation in mammals: overview and initial observations. Int J Low Radiat 1 (2003) 120-131
56. Elmore E., Lao X.-Y., Kapadia R., and Redpath J.L. The effect of dose rate on radiation-induced neoplastic transformation in vitro by low doses of low-LET radiation. Radiat Res 166 (2006) 832-838
57. Euvrard S., Kanitakis J., and Claudis D. Skin cancers after organ transplantation. N Engl J Med 348 (2003) 1681-1691
58. Feinendegen A.P. Epigenetics at the epicenter of modern medicine. J Am Med Assoc 299 (2008) 1845-1850
59. Feinendegen L.E. Reactive oxygen species in cell responses to toxic agents. Hum Exp Toxicol 21 (2002) 85-90
60. Feinendegen L.E. Significance of basic and clinical research in radiation medicine: challenges for the future. Br J Radiol 78 (2005) 1-11
61. Feinendegen L.E., Pollycove M., and Neumann R.D. Whole-body responses to low-level radiation exposure: New concepts in mammalian radiobiology. Exp Hematol 35 (2007) 37-46
62. Franco N., Lamartine J., Frouin V., Le Minter P., Petat C., Leplat J.J., et al. Low-dose exposure to ( rays induces specific gene regulations in normal human keratinocytes. Radiat Res 163 (2005) 623-635
63. Franklyn J.A., Maisonneuve L., Sheppard M., Betteridge T., and Boyle P. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population based study. Lancet 353 (1999) 2111-2115
64. Gould M.N. Radiation initiation of carcinogenesis in vivo: a rare or common cellular event. In: Boice Jr. J.D., and Fraumeni Jr. J.F. (Eds). Radiation carcinogenesis: epidemiology and biological significance (1984), Raven Press, New York 347-358
65. Hall E.J. Intensity modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65 (2006) 1-7
66. Hall E.J., and Cheng-Shie W. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56 (2003) 83-88
67. Hall E.J., and Giaccia A. Radiobiology for the radiologist (2006), Lippincott, Williams and Wilkins
68. Hayata I., Wang C., Zhang W., Chen D., Minamihisamatsu M., Morishima H., et al. Effect of high level natural radiation on chromosomes of residents in southern china. Cytogenet Genome Res 104 (2004) 237-239
69. Hickman J.A. Apoptosis and tumorigenesis. Cur Opin Cell Biol 12 (2002) 67-72
70. Hoeijmakers J.H.J. Genome maintenance mechanisms for preventing cancer. Nature 411 (2001) 366-374
71. IARC. Monograph on the evaluation of carcinogenic risks to humans. Vol. 75, Ionizing radiation, part I, X and gamma radiation and neutrons. IARC, Lyon, 2000.
72. IARC, Académie de Médecine, Académie des Sciences, Fédération des Centres de Lutte Contre le Cancer. Attributable Causes of Cancer in France in the Year 2000. IARC, Lyon, 2007. IARC Working Group Reports Vol 3, 172 pages.
73. ICRP, Low-Dose Extrapolation of Radiation-Related Cancer Risk. Publication 99, International Commission on Radiological Protection. Elsevier, Amsterdam, 2006.
74. Ilnytsky Y., Koturbash I., and Kovalchuk O. Radiation-induced bystander effects in vivo are epigenetically regulated in a tissue specific manner. Environ Mol Mutagenesis 50 (2009) 105-113
75. Kadhim M.A., Hill M.A., and Moore S.R. Genomic instability and the role of radiation quality. Radiat Prot Dosimetry 122 (2006) 221-227
76. Kennedy A.R., and Little J. Evidence that a second event in X-ray induced oncogenic transformation in vitro occurs during cellular proliferation. Radiat Res 99 (1984) 228-248
77. Kinlen L. Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet 2 (1988) 1323-1327
78. Kleinerman R.A. Cancer risks following diagnosis and therapeutic radiation exposure in children. Pediatr Radiol 36 Suppl. 14 (2006) 121-125
79. Koh E.S., Tran T.H., Heydarian M., Sachs R.K., Tsang R.W., Brenner D.J., et al. A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk. Radiat Oncol 2 (2007) 13
80. Kony S.J., de Vathaire F., Chompret A., Shamsaldim A., Grimaud E., Raquin M.A., et al. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 350 (1997) 91-96
81. Koscielny S., and Tubiana M. The link between local recurrence and distant metastases in human breast cancer. Int J Radiat Oncol Biol Phys 45 (1999) 245-246
82. Kry S.F., Followill D., White R.A., et al. Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1265-1271
83. Kryscio A., Ulrich Müller W.-U., Wojcik A., Kotschy N., Grobelny S., and Streffer C. A cytogenetic analysis of the long-term effect of uranium mining on peripheral lymphocytes using the micronucleus-centromere assay. Int J Radiat Biol (2001) 1087-1093
84. Le Pogam MA, Rubino C, Diallo I et al. Radiation dose fractionation and second cancer risks after breast cancer treatment. Radiat Prot Dosimetry 2008. (in press).
85. Liauw S.L., Sylvester J.E., Morris C.G., Blasko J.C., and Grimm P.D. Second malignancies after prostate brachytherapy : incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys 66 (2006) 669-673
86. Little M.P. Comparisons of the risk of cancer incidence and mortality following radiation therapy for benign or malignant disease with cancer risks observed in the Japanese A-bomb survivors. Int J Radiat Biol 77 (2000) 431-464
87. Little M.P., and Muirhead C.R. Evidence for cuvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors. Int J Radiat Biol 70 (1996) 83-94
88. Little M.P., de Vathaire F., Charles M.W., Hawkins M.M., and Muirhead C.R. Variations with time and age in the risks of solid cancer incidence after radiation exposure in childhood. Stat Med 17 (1998) 1341-1355
89. Little M.P., and Muirhead C.R. Derivation of low dose extrapolation factors from analysis of the curvature in the cancer indicence dose response in Japanese atomic bomb survivors. Int J Radiat Biol 76 (2000) 939-953
90. Little M.P., Hoel D.G., Molitor J., Boice JDJr, Wakeford R., and Muirhead C.R. New models for evaluation of radiation-induced lifetime cancer risk and its uncertainty employed in the UNSCEAR 2006 report. Radiat Res 169 (2008) 660-676
91. Little M.P., Wakeford R., Tawn E.J., Bouffler S.D., and Berrington de Gonzalez A. Risks associated with low doses and low dose-rates of ionizing radiation: why linearity may be (almost) the best we can do. Radiology 251 (2009) 6-12
92. Liu Z., Mothersill C.E., McNeill F.E., Lyng F.M., Byun S.H., Seymour C.B., et al. A dose threshold for a medium transfer bystander effect for a human skin cell line. Radiat Res 166 (2006) 19-23
93. Loeffler J., Niermierk A., and Chapman P. Second tumor after radiosurgery: Tip of the iceberg or a bump in the road?. Neurosurgery 52 (2003) 1436-1442
94. Loucas B.D., Eberle R., Bailey S.M., and Cornforth M.N. Influence of dose rate on the induction of simple and complex chromosome exchanges by gamma rays. Radiat Res 162 (2004) 339-349
95. Lundell M., Mattsson A., Hakulinen T., and Holm L.E. Breast cancer after radiotherapy for skin hemagioma in infancy. Radiat Res 145 (1996) 225-230
96. Marples B., Wouters B.G., Collis S.J., Chalmers A.J., and Joiner M.C. Low-dose hyper-radiosensitivity: a consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells. Radiat Res 161 (2004) 247-255
97. Marx J. Debate surges over the origins of genomic defects in cancer. Science 5581 (2002) 544-546
98. Miller A.B., Howe G.R., Sherman G.J., Lindsay J.P., Yaffe M.J., Dinner P.J., et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 321 (1989) 1285-1289
99. M'Kacher R., Bennaceur-Griscelli A., Girinsky T., Koscielny S., Delhommeau F., Dossou J., et al. Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment and predictive of second cancers. Int J Radiat Oncol Biol Phys 68 (2007) 465-471
100. Monier R., and Tubiana M. Cancérogenèse : Accroissement des connaissances et évolution des concepts. Oncologie 10 (2008) 319-347
101. Moon K., Stukenborg G.J., Hein S., and Theodorescu D. Cancer incidence after localized therapy for prostate. Cancer 107 (2006) 991-998
102. Morgan W.F. Will radiation-induced bystander effects or adaptive responses impact on the shape of the dose response relationships at low doses of ionizing radiation. Dose Response 4 (2006) 257-262
103. Mothersill C., and Seymour C.B. Radiation-induced bystander effects and the DNA paradigm: an "out of field" perspective. Mutat Res 59 (2006) 5-10
104. Muirhead C.R., O'Hagan J.A., Haylock R.G.E., Phillipson M.A., Willcock T., Berridge G.L.C., et al. Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers. Brit J Cancer 100 (2009) 206-212
105. Nair R.R., Rajan B., Akiba S., Jayalekshmi P., Nair M.K., Gangadharan P., et al. Background radiation and cancer incidence in Kerala. India-Karanagappally cohort study. Health Phys 96 (2009) 55-66
106. Naumburg E., Bellocco R., Cnattingius S., Jonzon A., Ekbom A., et al. Intrauterine exposure to diagnostic of X rays and risk of childhood leukemia subtypes. Radiat Res 156 (2002) 718-723
107. Neugut A.I., Murray T., Santos J., Amols H., Hayes M.K., Flannery J.T., et al. Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer 73 (1994) 1615-1620
108. Nguyen F., Rubino C., Guerin S., Diallo I., Samand A., Hawkins M., et al. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields. Int J Radiat Oncol Biol Phys 70 (2008) 908-915
109. Norppa H., Bonassi S., Hansteen I.L., Hagmar L., Strömberg U., Rössner P., et al. Chromosome aberrations and SCEs as biomarkers of cancer risk. Mutat Res 600 (2006) 37-45
110. Nyberg U., Nilsson B., Travis L.B., Holm L.E., and Hall P. Cancer incidence among Swedish patients exposed to radioactive thorotrast: a forty-year follow-up survey. Radiat Res 157 (2002) 419-425
111. Okada M., Okabe A., Uchihori Y., Kitamura H., Sekine E., Ebisawa S., et al. Single extreme low dose/low dose rate irradiation causes alteration in lifespan and genome instability in primary human cells. Br J Cancer 96 (2007) 1707-1710
112. Ott O.J., Hildebrandt G., Pötter R., Hammer J., Lotter M., Resch A., et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multicentre trial. Radiother Oncol 82 (2007) 281-286
113. Paganetti H. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy. Int J Radiat Oncol Biol Phys 63 (2005) 892-900
114. Pierquin B., Tubiana M., Pan C., Lagrange J.L., Calitchi E., and Otmezguine Y. Long-term results of breast cancer irradiation treatment with low-dose-rate external irradiation. Int J Radiat Oncol Biol Phys 67 (2007) 117-121
115. Portess D.I., Bauer G., Hill M.A., and O'Neill P. Low-dose irradiation on nontransformed cells stimulates the selective removal of precancerous cells via intercellular induction of apoptosis. Cancer Res 67 (2007) 1246-1253
116. Preston D.L., Ron E., Tokuoka S., Funamoto S., Nishi N., Soda M., et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 168 (2007) 1-64
117. Prochazka M., Hall P., Gagliardi G., Granath F., Nilsson B.N., Shields P.G., et al. Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer. J Clin Oncol 23 (2005) 7467-7474
118. Radisky D.C., Bissell M.J., and Cancer. Science. Respect thy neighbor! 303 (2004) 774-775
119. Richiardi L., Scelo G., Boffetta P., Hemminki K., Pukkala E., Olsen J.H., et al. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries. Int J Cancer 120 (2006) 623-636
120. Ronckers C.M., Doody M.M., Lonstein J.E., Stovall M., and Land C.E. Multiple diagnostic X-rays for spine deformities and risk of breast cancer. Cancer Epidemiol Biomarkers Prevent 17 (2008) 605-613
121. Rosso S., Zanetti R., Martinez C., Tormo M.J., Schraub S., Sancho-Garnier H., et al. The multicenter South European study Helios. II - Different sun expsosure patterns in the etiology of basal-cell and squamous-cell carcinomag of the skin. Brit J Cancer 73 (1996) 1447-1454
122. Rothkamm K., and Löbrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci USA 100 (2003) 5057-5062
123. Rubino C., Adjadj E., Doyon F., Shamsaldin A., Abbas T.M., Caillou B., et al. Radiation exposure and familial aggregation of cancer as risk factors for colorectal cancer after radioiodine treatment for thyroid carcinoma. Int J Radiat Oncol Biol Phys 62 (2005) 1084-1089
124. Rubino C., de Vathaire F., Shamsaldin A., Labbe M., and Lê M.G. Radiation dose chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Brit J Cancer 89 (2003) 840-846
125. Rudant J., Baccaini B., Ripert M., Goubin A., Bellec S., Hémon D., et al. Population-mixing at the place of residence at the time of birth and incidence of childhood leukaemia in France. Eur J Cancer 42 (2006) 927-933
126. Scelo G., Boffetta P., Hemminki K., Pukkala E., Olsen J.H., Andersen A., et al. Association between small intestine cancer and other primary cancers: An international population-based study. Int J Cancer 118 (2006) 189-196
127. Schmitt C.A. Cellular senescence and cancer treatment. Biochim Biophys Acta 1775 (2007) 5-20
128. Scott B. Risk of thyroid cancer after exposure to 131 I in childhood. Response Cardis E, Kesminienne A. J. Nat. Cancer Inst 98 (2006) 561
129. Scott B., Sanders C., Mitchel R.E.J., and Borcham D.J. CT scans may reduce rather than increase the risk of cancer. J Am Phys Surg 13 (2008) 8-11
130. Shu X.O., Potter J.D., Linet M.S., Severson R.K., Han D., Kersey J.H., et al. Diagnostic X rays and ultrasound exposure and risk of childhood acute lymphoblastic leukemia by immunophenotype. Cancer Epidemiol Biomark Prev 11 (2002) 177-185
131. Sigurdson A.J., and Jones I.M. Second cancers after radiotherapy: any evidence for radiation-induced genomic instability?. Oncogene 22 (2003) 7018-7027
132. Sigurdson A.J., Land C.E., Bhatti P., Pineda M., Brenner A., Carr Z., et al. Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. Radiat Res 171 (2009) 77-88
133. Smith R.W., Wang J., Bucking C.P., Mothersill C.E., and Seymour C.B. Evidence for a protective response by the gill proteome of rainbow trout exposed to X-ray induced bystander signals. Proteomics 7 (2007) 4171-4180
134. Sokolov MV, Smirnova NA, Camerini-Otero RD, Neumann RD, Panyutin IG. Microarray analysis of differentially expressed genes after exposure of normal humanfibroblasts to ionizing radiation from an external source and from DNA-incorporated iodine-125 radionuclide. Gene 200; 382: 47-56.
135. Soria J.C., Rodriguez M., Liu D.D., Lee J., Hong W.K., and Mao L. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Res 62 (2003) 351-355
136. Stewart A.M., Webb K.W., and Hewitt D. A survey of childhood malignancies. Br Med J 1 (1958) 1495-1508
137. Streffer C. Bystander effects, adaptive response and genomic instability induced by prenatal irradiation. Review Mutat Res 568 (2004) 79-87
138. Strzelczyk J., Potter W., and Zdrojewicz Z. Rad-By-Rad (Bit-by-Bit): Triumph of evidence over activities fostering fear of radiogenic cancers at low doses. Dose-Response 5 (2007) 275-283
139. Suit H., Goldberg S., Niemierko A., Ancukiewicz M., Hall E., Goitein M., et al. Secondary carcinogenesis in patients treated with Radiation: A review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res 167 (2007) 12-42
140. Svahn-Tapper G., Garwicz S., Anderson H., Shamsaldin A., De Vathaire F., Olsen J.H., et al. Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: a population-based case-control study in the five Nordic countries. Acta Oncol 45 (2006) 438-448
141. Tanooka H. Threshold dose-response in radiation carcinogenesis: an approach from chronic beta-irradiation experiments and a review of non tumour doses. Int J Radiat Biol 77 (2001) 541-551
142. Taubes G. Epidemiology faces its limits. Science 269 (1995) 164-169
143. Thomas C., Fertil B., and Foray N. Hyperradiosensibilité aux très faibles doses: impact en radiothérapie des micrométastases. Cancer Radiother 11 (2007) 260-265
144. Trott K.R. Second cancers after radiotherapy. In: van der Kogel, and Joiner (Eds). Basic clinical radiobiology (2009), Hodder publ, London
145. Tubiana M. Late mortality in Hodgkin's disease: can we reduce it?. Ann Oncol 13 Suppl. 1 (2002) 5-9
146. Tubiana M (ed.) Radiobiologie. Hermann/Médecine, Paris 2008.(502 pages).
147. Tubiana M. The linear no-threshold relationship and advances in our understanding of carcinogenesis. Int J Low Rad 5 (2008) 173-204
148. Tubiana M. Can we reduce the incidence of Second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 91 (2009) 4-15
149. Tubiana M., and Koscielny S. The natural history of breast cancer and the link between local recurrence and distant metastases: implications for therapy. Rep Pract Oncol Radiother 6 (2001) 181-195
150. Tubiana M., Aurengo A., Masse A.J., and Valleron A.J. Risk of cancer from diagnostic X-rays. Lancet 363 (2004) 1908
151. Tubiana M., Aurengo A., Averbeck D., and Masse R. The debate on the use of linear no threshhold for assessing the effects of low doses. J Radiol Prot 26 (2006) 317-324
152. Tubiana M., Masse R., de Vathaire F., Averbeck D., and Aurengo A. La controverse sur les effets des faibles doses de rayonnements ionisants et la relation linéaire sans seuil. Radioprotection 42 (2007) 133-161
153. Tubiana M., Feinendegen L., Yang C., and Kaminski J.M. The linear no-threshold relationship is inconsistent with radiobiological and experimental data. Radiology 251 (2009) 13-22
154. Van Kaick G., Dalheimer A., Hornik S., Kaul A., Liebermann D., Lührs H., et al. The German Thorostrast Study: Recent results and assessment of risks. Radiat Res 152 (1999) S64-S72
155. Veronesi U., Gatti G., Luini A., Intra M., Orecchia R., Borgen P., et al. Intraoperative radiation therapy for breast cancer: technical notes. Breast J 9 (2003) 106-112
156. Vilenchik M.M., and Knudson A.G. Inverse radiation dose-rate effects on somatic and germ-line mutations and DNA damage rates. Proc Natl Acad Sci USA 97 (2000) 5381-5386
157. Vilenchik M.M., and Knudson A.G. Endogenous DNA double-strand break production, fidelity of repair and induction of cancer. Proc Natl Acad Sc USA 103 (2003) 17874-17875
158. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat Med 10 (2004) 789-799
159. Walinder G. Has Radiation Protection Become a Health Hazard? Swedish Nuclear Training and Safety Centre, Nykoping, Sweden. Madison, Wis: Med Phys Publishing, 1995; 16-63, 95- 117, 128-137.
160. Wall B.F., Kendall G.M., Edwards A.A., Bouffler S., Muirhead C.R., and Meara J.R. What are the risks from medical X-rays and other low dose radiation? Br. J. Radiol 79 (2006) 285-294
161. Weinberg R.A. The biology of cancer (2007), Taylor & Francis, New York
162. Wolff S. The adaptive response in radiobiology: evolving insights and implications. Environ Health Perspect 106 (1998) 277-283
163. Yamamoto O., Seyama T., Ito A., and Fujimoto N. Oral administration of tritiated water (THO) in mouse. III: Low dose-rate irradiation and threshold dose-rate for radiation risk. Int J Radiat Biol 73 (1998) 535-541